The WCCT Global study called for 60 patients. The organization effectively screened 130 glaucoma patients and randomized the first 48 of these patients.
More Articles on Ophthalmology:
Data Safety Monitoring Board Approves Third Cohort in Advanced Cell Technology Clinical Trials
EyeTechCare Receives $13M in Funding
10 Statistics on Ophthalmologist Compensation by Location
WCCT Global Completes Fourth Cohort of 48 Patient Clinical Study
WCCT Global, a contract research organization focusing on drug development, announced that is has successfully finished four cohorts in the study of 48 glaucoma patients.
EHR switches without disruption: What ambulatory leaders need to know
Recommended Live Webinar on Dec 2, 2025 1:00 PM - 2:00 PM CST